Learn what to expect during DEA inspections and how to protect your practice with proactive preparation strategies.
View Article >>Discuss the DEA/HHS joint rule extending the prescribing flexibilities for controlled substances. Include: 1) an overview of the prescribing flexibilities that emerged during the COVID pandemic re: controlled substances; 2) the details of the proposed rule, and 3) what the rule means for providers.
View Article >>DEA registration applications are receiving increased scrutiny as DEA turns its sights on providers and pharmacies to curtail controlled substance misuse and abuse. Applicants can and should take steps to ensure the registration process moves as quickly and smoothly as possible.
View Article >>Texas pharmacies are facing increasing scrutiny by the Board of Pharmacy, which is working closely with the DEA and other federal agencies, to investigate regulatory violations and Medicaid claims.
View Article >>HLA's Nancy Coffey, a former government official and healthcare expert, has been appointed to serve a three-year term as an independent pharmacy monitor for the Commonwealth of Massachusetts.
View Article >>